A Case of Pulmonary Embolism after to Receiving a Dose of Sildenafil
Abstract
Introduction: Several studies have posited the potential of PDE5Is to precipitate arterial and venous thrombotic or embolic incidents, albeit rare occurrences. The present investigation documents a case of pulmonary thromboembolism (PTE) in an elderly male patient, aged 81, following the consumption of sildenafil. Case Report: An 81-year-old male patient who was previously diagnosed with syncope was admitted to our Emergency Department. He reported symptoms of dyspnea and vertigo. Approximately two hours before admission, there was a history of accidentally ingesting a total dose of 100 milligrams of sildenafil. Conclusion: The occurrence of PTE after sildenafil administration in this case, albeit rare, underscores the significance of meticulous evaluation of medications during patient history-taking. This case report, the importance of thorough efforts to rule out the diagnosis of PTE and to address even the slightest suspicion.
Read the paper
Related studies
- 2024 update in heart failure
- Vascular involvement in idiopathic pulmonary fibrosis
- A novel technique- subendometrial autologous platelet rich plasma injection in patients with unresponsive thin endometrium undergoing frozen-thawed embryo transfer: a prospective cohort study
- Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial
- Combined Pulmonary Fibrosis and Emphysema (CPFE): A "New" Smoking-Related Interstitial Lung Disease (ILD)
- Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.